verified SJR 4,008 · Q1 • database Scopus / SJR & Web of Science indexed

United States · Cell Press

workspace_premium Q1 — Molecular Biology lock_open Open Access Unclaimed

Molecular Therapy

Molecular Therapy is a journal indexed in SJR in Molecular Biology and Medicine (miscellaneous) with an H index of 220. It has a price of 2500 €. It has an SJR impact factor of 4,008 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 4,008.

Molecular Therapy focuses its scope in these topics and keywords: gene, cells, vectors, delivery, virus, muscle, therapy, aav, adenoassociated, administration, ...

ISSN: 1525-0016

Editorial: Cell Press

Category: Molecular Biology

Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD

schedule Datos CoP · solo campos en BD

SJR Impact Factor trending_up

4,008 Q1

H-index 220

Tasa de Aceptación pie_chart

20% Selectiva

Fuente Acceptance_Rate

Tiempo a publicación hourglass_top

NPD

Campo Sin dato

Coste de Publicación (APC) payments

2.500 € Open Access

Ruta Non-OA 0 €

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

4,008

H-index

220

Docs (year)

374

Docs 3y

870

Total refs

20074

Cites 3y

8816

Citable 3y

737

Cites/Doc 2y

9.4

Ref/Doc

53.67

Immediate OA

2500 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

AIDS: No End in Sight

Will Engineered T Cells Expressing CD20 scFv Eradicate Melanoma?

DNA Vaccines Encoding Ii-PADRE Generates Potent PADRE-specific CD4+ T-Cell Immune Responses and Enhances Vaccine Potency

Direct Genetic Correction as a New Method for Diagnosis and Molecular Characterization of MHC Class II Deficiency

Development of a sensitive assay for detection of replication-competent recombinant lentivirus in large-scale HIV-based vector preparations

Decreased Insulitis and Blood Glucose Levels after Injection of GAD-Transduced Lymphocytes into NOD Mice

Corrigendum to "The Effect of Sequestration by Nontarget Tissues on Anti-tumor Efficacy of Systemically Applied, Conditionally Replicating Adenovirus Vectors"

Contribution of Toll-like Receptor 9 Signaling to the Acute Inflammatory Response to Nonviral Vectors

Contradictions and extremes

Chicken HS4 Insulators Have Minimal Barrier Function Among Progeny of Human Hematopoietic Cells Transduced With an HIV1-based Lentiviral Vector

Chance or necessity? Insertional Mutagenesis in Gene Therapy and Its Consequences

beta-Amino Ester Polymers Facilitate in Vivo DNA Transfection and Adjuvant Plasmid DNA Immunization

SHOW MORE ARTICLES

Baculovirus-based Vaccination Vectors Allow for Efficient Induction of Immune Responses Against Plasmodium falciparum Circumsporozoite Protein

499. Intravenous Delivery of a Novel Micro-Dystrophin Vector Prevented Muscle Deterioration in Young Adult Canine Duchenne Muscular Dystrophy Dogs

Aging-related Decrease of Human ASC Angiogenic Potential Is Reversed by Hypoxia Preconditioning Through ROS Production

Adenoviral-Mediated Suicide Gene Therapy for Ovarian Cancer

Adeno-Associated Virus Mediates Long-Term Gene Transfer and Delivery of Chondroprotective IL-4 to Murine Synovium

Adaptive Immune Response Impairs the Efficacy of Autologous Transplantation of Engineered Stem Cells in Dystrophic Dogs

Activation of the Extracellular Signal-Regulated Kinase 1/2 Pathway by AAV Gene Transfer Protects Retinal Ganglion Cells in Glaucoma

AAV2-mediated ocular gene therapy for infantile neuronal ceroid lipofuscinosis

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

A Quantitative Method for Measuring Gene Expression Magnitude and Volume Delivered by Gene Therapy Vectors

A Novel ex Vivo Angiogenesis Assay Based on Electroporation-Mediated Delivery of Naked Plasmid DNA to Skeletal Muscle

A new peptide ligand that targets particles and heterologous proteins to hepatocytes in vivo

FAQS

In Country of Papers you can find SJR impact factor and other metrics to help you decide on a Journal.